Latest News

FDA okays $2M medicine, most expensive ever
Tuesday, May 28, 2019 IST
FDA okays $2M medicine, most expensive ever

It helps treat an inherited condition called spinal muscular atrophy

 
 

U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of those with the most common type of the disease within a couple of years.
 
The treatment is priced at $2.125 million (About 14 crore rupees). Out-of-pocket costs for patients will vary based on insurance coverage.
 
The medicine, sold by the Swiss drugmaker Novartis, is a gene therapy that treats an inherited condition called spinal muscular atrophy. The treatment targets a defective gene that weakens a child’s muscles so dramatically that they become unable to move, and eventually unable to swallow or breathe. It strikes about 400 babies born in the U.S. each year.
 
The Food and Drug Administration on May 24 approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test to have any of the three types of the disease. The therapy is a one-time infusion that takes about an hour.
 
Insurance coverage
 
Novartis said it will let insurers make payments over five years, at $425,000 per year, and will give partial rebates if the treatment doesn’t work.
 
The one other medicine for the disease approved in the U.S. is a drug called Spinraza. Instead of a one-time treatment, it must be given every four months. Biogen, Spinraza’s maker, charges a list price of $750,000 for the first year and then $350,000 per year after that.
 
The independent nonprofit group Institute for Clinical and Economic Review, which rates the value of expensive new medicines, calculated that the price of the new gene therapy is justifiable at a cost of $1.2 million to $2.1 million because it “dramatically transforms the lives of families affected by this devastating disease.”
 
ICER’s president, Dr. Steven D. Pearson, called the treatment’s price “a positive outcome for patients and the entire health system.”
 
Gene target
 
The defective gene that causes spinal muscular atrophy prevents the body from making enough of a protein that allows nerves that control movement to work normally. The nerves die off without the protein.
 
In the most common type, which is also the most severe, at least 90% of patients die by age 2, and any still alive need a ventilator to breathe. Children with less-severe types become disabled more slowly and can live for up to a couple decades.
 
Zolgensma works by supplying a healthy copy of the faulty gene, which allows nerve cells to then start producing the needed protein. That halts deterioration of the nerve cells and allows the baby to develop more normally.
 
In patient testing, babies with the most severe form of the disease who got Zolgensma within 6 months of birth had limited muscle problems. Those who got the treatment earliest did best.
 
Babies given Zolgensma after six months stopped losing muscle control, but the medicine can’t reverse damage already done.
 

 
 

Early diagnosis is crucial
 
Evelyn Villarreal was one of the first children treated, at eight weeks. Her family, from Centreville, Virginia, had lost their first child to spinal muscular atrophy at 15 months. Two years later when Evelyn was born a test showed she also had the disease, so the family enrolled her in the gene therapy study at Nationwide Children’s Hospital in Columbus, Ohio.
 
Evelyn is now 4 years old and showing no muscle problems other than minor trouble standing up, said her mother, Elena Villarreal. She has been feeding herself for a long time, she draws and speaks well, and will be starting kindergarten in the fall.
 
“She’s very active and goes to the playground a lot,” said Elena Villarreal. “She’s walking and even jumping.”
 
It is too early to know how long the benefit of the treatment lasts, but doctors’ hopes are rising that they could last a lifetime, according to Dr. Jerry Mendell, a neurologist at Nationwide Children’s. Mendell led one of the early patient studies and is Evelyn’s doctor.
 
“It’s beginning to look that way,” he said, because a few children treated who are now 4 or 5 still have no symptoms.
 
Early diagnosis is crucial, so Novartis has been working with states to get genetic testing for newborns required at birth. It expects most states will have that requirement by next year.
 
The FDA said side effects included vomiting and potential liver damage, so patients must be monitored for the first few months after treatment.
 

 
 
 
 
 

Related Topics

 
 
 

Trending News & Articles

 Article
12 Early Signs Of Lung Cancer To Never Ignore

Lung cancer is usually not noticeable during the early stages. Most people are diagnosed when the disease is at an advanced stage. According to Cancer.org, it is ...

Recently posted . 7K views . 2 min read
 

 Article
11 Surprising Benefits Of Wood Apple Or Bael Fruit

The health benefits of wood apple include [1] relief from constipation, indigestion, peptic ulcer, piles, respiratory problems, diarrhea, and dysentery. It also b...

Recently posted . 4K views . 2 min read
 

 Article
10 Amazing Benefits Of Bael (Kaitha)

Bael, also known as the “Wood Apple”, is a species native to India. The bael tree is considered to be sacred to the Hindus. A famous drink known as sh...

Recently posted . 4K views . 2 min read
 

 Article
These 7 Remedies Can Remove The Milia (Milk Spots) From Your Face

Do you know what milia are? Milia is a skin condition which causes the appearance of small white hard bumps on the skin which usually appear on the face, neck or ch...

Recently posted . 4K views . 2 min read
 

 
 

More in Food & Health

 Article
Poha is ideal breakfast and great for weight loss

Poha, a popular Indian breakfast made with beaten rice, has variations in different parts of the country. In Uttar Pradesh and some parts of Rajasthan, poha is se...

Recently posted. 807 views . 2 min read
 

 Article
You could be suffering from eating disorder if you are diabetic

As many as one-third of young women with diabetes may be struggling with a type of eating disease that prompts them to manipulate or omit insulin intake main to exc...

Recently posted. 731 views . 15 min read
 

 Article
It pays to choose local, indigenous ingredients, because we live on the land they grow in

Even after building and launching our own rockets, we look to the West when it comes to nutrition. For whatever reason, when health, fitness or fat loss ...

Recently posted. 639 views . 4 min read
 

 Reviews
The 10 Best Restaurants Near India Gate, New Delhi



Recently posted . 1K views . 58 min read
 

 Article
Netflix addiction: Nimhans gets its first case, 12 signs you’re addicted to Netflix

Nimhans in Bengaluru received its first case of ‘Netflix addiction’, says report. Watch out for these 12 possible signs you're addicted to Netflix...

Recently posted. 967 views . 1 min read
 

 Article
Mobile tower radiation increasing risk of oral problems

The statement came after the extraction of 526 teeth from the mouth of a seven-year-old boy in a rare surgery performed at the hospital.  

Recently posted. 760 views . 1 min read
 

 
 
 

   Prashnavali

  Thought of the Day

“Reading is to the mind what exercise is to the body.”
Anonymous

Be the first one to comment on this story

Close
Post Comment
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST
Shibu Chandran
2 hours ago

Serving political interests in another person's illness is the lowest form of human value. A 70+ y old lady has cancer.

November 28, 2016 05:00 IST


ads
Back To Top